Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for ENDRA Life Sciences Inc. (NDRA : NSDQ)

• Company Description    ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. ENDRA Life Sciences Inc. is based in Ann Arbor, United States. Number of Employees: 22

• Price / Volume Information    Yesterday's Closing Price: $0.19 Daily Weekly Monthly 20 Day Moving Average: 2,110,655 shares Shares Outstanding: 44.09 (millions) Market Capitalization: $8.48 (millions) Beta: 1.40 52 Week High: $2.44 52 Week Low: $0.18 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -25.47% -18.66% 12 Week -53.45% -50.99% Year To Date -72.20% -67.60%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 3600 GREEN COURT SUITE 350 - ANN ARBOR,MI 48105 USA ph: 734-335-0468 fax: - ndra@mzgroup.us http://www.endrainc.com

• General Corporate Information    Officers Francois Michelon - Chief Executive Officer and Director Irina Pestrikova - Director Louis J. Basenese - Director Anthony DiGiandomenico - Director Michael Harsh - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 29273B104 SIC: 3845 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/11/22 Share - Related Items Shares Outstanding: 44.09 Most Recent Split Date: (:1) Beta: 1.40 Market Capitalization: $8.48 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.05 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.19 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/11/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.93 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -16.67% vs. Previous Quarter: 0.00% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/22 - -98.50 12/31/21 - -79.12 09/30/21 - -78.44 ROA 03/31/22 - -83.88 12/31/21 - -69.83 09/30/21 - -69.25 Current Ratio 03/31/22 - 7.45 12/31/21 - 7.83 09/30/21 - 9.18 Quick Ratio 03/31/22 - 6.03 12/31/21 - 7.00 09/30/21 - 8.22 Operating Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Net Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Pre-Tax Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Book Value 03/31/22 - 0.21 12/31/21 - 0.26 09/30/21 - 0.31 Inventory Turnover 03/31/22 - 0.00 12/31/21 - 0.00 09/30/21 - 0.00 Debt-to-Equity 03/31/22 - 0.00 12/31/21 - 0.00 09/30/21 - 0.00 Debt-to-Capital 03/31/22 - 0.31 12/31/21 - 0.26 09/30/21 - 0.22

Powered by Zacks Investment Research ©